Cargando…
Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19
Severe coronavirus disease-19 (COVID-19) is characterized by vascular inflammation and thrombosis. We and others have proposed that the inflammatory response to coronavirus infection activates endothelial cells, leading to endothelial release of pro-thrombotic proteins. These mediators can trigger o...
Autores principales: | Osburn, William O., Smith, Kimberly, Yanek, Lisa, Amat-Alcaron, Nuria, Thiemann, David R., Cox, Andrea L., Leucker, Thorsten M., Lowenstein, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119480/ https://www.ncbi.nlm.nih.gov/pubmed/35588115 http://dx.doi.org/10.1371/journal.pone.0268296 |
Ejemplares similares
-
Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication
por: Leucker, Thorsten M., et al.
Publicado: (2014) -
The transcriptional landscape of human liver endothelial cells
por: Toledano-Sanz, Pablo, et al.
Publicado: (2023) -
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
por: Leucker, Thorsten M., et al.
Publicado: (2021) -
High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro
por: Bouck, Emma G., et al.
Publicado: (2023) -
Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)